Catalyst Wire Dossier Catalyst Wire Dossier

XH-S004 Tablet

XH-S004 · S-INFINITY Pharmaceuticals Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XH-S004 Tablet, covering 2025-06-25 to 2025-06-25. Get the full timeline:

Most recent: Clinical Trial Update: The Phase Ib Clinical Trial of the XH-S004 Tablet in Patients With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate Its Safety, Tolerability, Pharmacokinetic Characteristics and Pharmacodynamic Characteristics After Multiple Administrations [Phase 1]

See pricing